-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Carisma Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
- Carisma Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $625K, a 89.4% increase year-over-year.
- Carisma Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $3.4M, a 371% increase year-over-year.
- Carisma Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.32M, a 742% increase from 2022.
- Carisma Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $275K, a 94.7% decline from 2021.
- Carisma Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.14M, a 193% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)